Analysis of the onset of lower urinary tract symptoms in multiple scleroris patients

• by Jan Krhut, Pavel Hradílek, Adéla Kondé, Barbora Skugarevská, Ivana Woznicová, Radek Paus Sýkora, Hanne Kobberø, Tomáš Rychlý, Peter Zvara

• May 31, 2025

Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial

Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS

• February 17, 2026

• 3 min

CSF Proteomics Identifies New Biomarkers for Multiple Sclerosis

Large-cohort CSF proteomics from the Mann Lab identifies a 22-protein panel distinguishing MS from related diseases

• March 11, 2026

• 3 min

Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium

Marcus Neuroscience Institute, part of Baptist Health South Florida, will host its two-day 2026 Brain & Spine Symposium on May 14 and 15.

• by

• April 6, 2026

• 3 min